BIO-TECHNE Corp Unrecognized Tax Benefits, Increase Resulting from Acquisition
BIO-TECHNE Corp (TECH) reported Unrecognized Tax Benefits, Increase Resulting from Acquisition of $960.00 thousand for the 12-month period ending 2022-06-30, per its 10-K filed 2024-08-22.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition · last filed 2024-08-22
- BIO-TECHNE Corp unrecognized tax benefits, increase resulting from acquisition for fiscal 2022 was $960.00K.
- BIO-TECHNE Corp unrecognized tax benefits, increase resulting from acquisition for fiscal 2020 was $0.00.
- BIO-TECHNE Corp unrecognized tax benefits, increase resulting from acquisition for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- BIO-TECHNE Corp unrecognized tax benefits, increase resulting from acquisition for fiscal 2018 was $900.00K, a 43.31% increase from fiscal 2017.
| Period end | Unrecognized Tax Benefits, Increase Resulting from Acquisition 12 month | Unrecognized Tax Benefits, Increase Resulting from Acquisition 12 month as first filed |
|---|---|---|
| 2022-06-30 | $960.00K 10-K · filed 2024-08-22 | |
| 2020-06-30 | $0.00 10-K · filed 2021-08-25 | |
| 2019-06-30 | $0.00 10-K · filed 2021-08-25 | $900.00K 10-K · filed 2019-08-28 |
| 2018-06-30 | $900.00K 10-K · filed 2021-08-25 | $0.00 10-K · filed 2020-08-26 |
| 2017-06-30 | $628.00K 10-K/A · filed 2019-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |